We use contamination monitors with gas (P-10) detectors. I have seen
I-125 implants alarm the waist area detectors after 18 months. The
implants did not alarm the portal monitors due to the metal casing. 

 

Curt Nason

Point Lepreau

 

________________________________

From: [email protected] [mailto:[email protected]] On Behalf
Of [email protected]
Sent: October 07, 2010 1:03 PM
To: [email protected]
Subject: Powernet: Anyone have experience with I-125 brachytherapy and
monitor response?

 

We have a  welder coming for our outage who has been treated for
prostate cancer with ~30 millicuries of I-125 brachytherapy seeds.
I-125 emits very low energy gammas, predominately 28 keV.  He should be
down to about 15 millicuries right now and we wonder if the NaI
detectors in the Whole Body Contamination Monitors will see those gammas
or if the energy discrimination (for which we don't have any data) and
will eliminate them.  Does anyone have any useful experience with I-125
and detectability by WBCM's and portal monitors?   We have to decide
very quickly whether to let this guy fly here for work.   Thanks, Eric 


Eric M. Goldin, CHP
Southern California Edison
<[email protected]>
This e-mail communication (including any or all attachments) is intended only 
for the use of the person or entity to which it is addressed and may contain 
confidential and/or privileged material. If you are not the intended recipient 
of this e-mail, any use, review, retransmission, distribution, dissemination, 
copying, printing, or other use of, or taking of any action in reliance upon 
this e-mail, is strictly prohibited. If you have received this e-mail in error, 
please contact the sender and delete the original and any copy of this e-mail 
and any printout thereof, immediately. Your co-operation is appreciated.
Le present courriel (y compris toute piece jointe) s'adresse uniquement a son 
destinataire, qu'il soit une personne ou un organisme, et pourrait comporter 
des renseignements privilegies ou confidentiels. Si vous n'etes pas le 
destinataire du courriel, il est interdit d'utiliser, de revoir, de 
retransmettre, de distribuer, de disseminer, de copier ou d'imprimer ce 
courriel, d'agir en vous y fiant ou de vous en servir de toute autre facon. Si 
vous avez recu le present courriel par erreur, priere de communiquer avec 
l'expediteur et d'eliminer l'original du courriel, ainsi que toute copie 
electronique ou imprimee de celui-ci, immediatement. Nous sommes reconnaissants 
de votre collaboration.

Reply via email to